Viruses as Therapeutics Flashcards

1
Q

Three uses of viruses in therapeutics

A
  1. Provide Gene Replacement Therapy
  2. Create recombinant vaccines to promote immunity to infectious agents and tumors
  3. Act as targeted killers of cancer cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gene therapy definition

A

The transfer of new genetic material to the cells of an individual with resulting benefit to the individual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Germline gene therapy vs. Somatic gene therapy

A

Germline: modifies gene that may be passed on to subsequent generation

Somatic: genetic modifications restricted to somatic cells, with no effect on the germline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Two general approaches to delivery

A
  • ex vivo: cells removed from patient and exposed to the vector in cell culture
  • in vivo: vector introduced directly into patient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Top 3 indications addressed by gene therapy clinical trials

A
  1. Cancer diseases
  2. Monogenic disease
  3. Infectious diseases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Top 3 gene types transferred in gene therapy clinical trials

A
  1. Antigen
  2. Cytokine
  3. Tumor supressor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Gene delivery agents

A
  • Viruses
  • Chemical - transfection
  • DNA loaded vesicles (liposomes)
  • DNA-protein complexes
  • Physical (microinjection - direct injection of DNA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

X-SCID is due to molecular defects in the gene for the _______ ______ ______

A

common gamma chain (γc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Retrovirus vectors for gene delivery

A
  • Replace viral genes with exogenous genes
  • Retain LTRs (integration), Ψ sequence (packaging)
  • Supply deleted gene products in trans
    • Packaging cell lines
    • Helper virus, helper plasmids
  • Infect cells to introduce exogenous genes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Creation of packaging line

A
  • Start with normal cultured cells
  • Transfect plasmid DNAs that will express gag, pol, and env proteins in cells
  • Genes encoding gag, pol, and env will integrate into the genome of the packaging cells
  • gag, pol and env proteins will be constitutively expressed in the packaging cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Transfecting vector plasmid with gene of interest into packaging cell line to produce vector particles

A
  • Vector plasmid will integrate into the genome of the packaging cells
  • Vector RNA will be transcribed by host-cell RNA polymerase
  • Vector RNA will be packaged into vector particles by the viral proteins that are being synthesized in the producer cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Retrovirus vectors

Advantages:

Disadvantages:

A

Advantages:

  • Efficient delivery of foreign genes
  • Control over host range, cell and tissue tropism

Disadvantages:

  • Random integration into chromosomes, insertional mutagenesis
  • Maintaining high levels of gene expression
  • Dependence on target cell proliferation with MMLV (leukemia)-based vectors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Retrovirus LTR contains a stron T-cell specific _______

A

enhancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Lentivirus Vectors

A

Preintegration complex with Vpr, integrase, and matrix protein will cross the nuclear membrane in nondividing cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lentivirus Vectors - Safety Concerns

A
  • Multi-plasmid systems for creating packaging cells
  • Self-inactivating vectors
    • Deletion in U3 region of right LTR
  • Control of vector tropism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Adenovirus - Basic Biology

A
  • Linear dsDNA genome
  • Replicates in the nucleus - no integration
  • Gene transcription regulated with immediate early, early and late classes of mRNAs
17
Q

Creating adenovirus construct

A
  • Delete certain viral genes to make room for therapeutic gene of interest
  • Some deleted viral genes are essential for the replication of adenovirus so they must be provided in trans by the complementing cell line
18
Q

Deliver of adenovirus vector construct

A
  • Transfect vector DNA construct into the complementing cell line (293 cells) to produce vector particles
  • Vector particles are used to deliver the therapeutic gene of interest into the target cells of the patient
    • Vector DNA enters the nucleus of the target cell but DOES NOT integrate
    • Therapeutic product synthesized in the cells that have been infected
19
Q

Adenovirus Vectors - Problems

A
  • Short term gene expression - no integration of recombinant DNA into host genome
  • Immune response - limits success of repeated use of vectors
  • Size restrictions on inserted genes
  • **Solutions: **Better packaging cell lines - “gutless vectors”
20
Q

Vaccinia Virus Expression Vectors - Biology

A
  • Large, dsDNA genome
  • Flexibility in the size of DNA that can be packaged
  • Cytoplasmic replication
  • Virus encoded enzyme
    • RNA polymerase
    • capping, methylating, polyadenylating
  • Viral promoters
    • Viral RNA polymerase, not cellular pol II
21
Q

Basic strategy for foreign gene expression with vaccinia vectors

A
  • Plasmid construction
    • Foreign gene + vaccinia promoter
  • Chimeric gene → vaccinia genome (homologous recombination)
  • Foreign gene → non-essential site in vaccinia genome
    • TK (Thymidine kinase) gene is the most popular site
    • Selection: TK(-) virus, TK(+) virus-BUdR sensitive
22
Q

Viruses as Oncolytics

A

Oncolytic Wild Viruses - some wild-type viruses have natural oncolytic activity in human tumors

Genetically manipulated viruses specifically targeted to infect and kill cancer cells

23
Q

Conditionally replicative Adenovirus (CRAd)

A

Modifications in adenovirus that allow tumor-specific tropism:

  • Deletion of E1A or E1B genomic regions - viruses will only replicated in cells with specific dysfunctions in cell cycle checkpoint pathways, like some cancer cells
  • Incorporation of tumor-specific promoters
  • Improvement of transduction efficiency in tumor cells, often accomplished by altering the virus cell attachment protein
24
Q

Reovirus (wild-type strain)

A

No modifications by recombinant DNA

  • Inherent tumor selectivity for cells with an activated Ras activity
  • In normal cells reovirus replication is restricted by the activation of the RNA-activated protein kinase (PKR)